Skip to main content
SpringerLink
Log in

A proof-of-concept study using [11C]flumazenil PET to demonstrate that pagoclone is a partial agonist

  • Letter to the Editors
  • Published:
Psychopharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  • Abadie P, Rioux P, Scatton B, Zarifian E, Barre L, Patat A, Baron JC (1996) Central benzodiazepine receptor occupancy by zolpidem in the human brain as assessed by positron emission tomography. Eur J Pharmacol 295(1):35–44

    Article  PubMed  CAS  Google Scholar 

  • Ball DM, Glue P, Wilson S, Nutt DJ (1991) Pharmacology of saccadic eye movements in man. 1. Effects of the benzodiazepine receptor ligands midazolam and flumazenil. Psychopharmacology 105:361–367

    Article  PubMed  CAS  Google Scholar 

  • Bateson A (2003) Pagoclone indevus. Curr Opin Investig Drugs 1:91–95

    Google Scholar 

  • Doble A, Canton T, Dreisler S, Piot O, Boireau A, Stutzmann JM, Bardone MC, Rataud J, Roux M, Roussel G et al (1993) RP 59037 and RP 60503: anxiolytic cyclopyrrolone derivatives with low sedative potential. interaction with the gamma-aminobutyric acidA/benzodiazepine receptor complex and behavioral effects in the rodent. J Pharmacol Exp Ther 266(3):1213–1226

    PubMed  CAS  Google Scholar 

  • Facklam M, Schoch P, Bonetti EP, Jenck F, Martin JR, Moreau JL, Haefely WE (1992) Relationship between benzodiazepine receptor occupancy and functional effects in vivo of four ligands of differing intrinsic efficacies. J Pharmacol Exp Ther 261(3):1113–1121

    PubMed  CAS  Google Scholar 

  • Malizia AL, Gunn RN, Wilson SJ, Waters SH, Bloomfield PM, Cunningham VJ, Nutt DJ (1996) Benzodiazepine site pharmacokinetic/pharmacodynamic quantification in man: direct measurement of drug occupancy and effects on the human brain in vivo. Neuropharmacology 35(9–10):1483–1491

    Article  PubMed  CAS  Google Scholar 

  • Malizia AL, Cunningham VJ, Bell CJ, Liddle PF, Jones T, Nutt DJ (1998) Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. Arch Gen Psychiatry 55(8):715–720

    Article  PubMed  CAS  Google Scholar 

  • National Institute for Clinical Excellence (2004) Management of anxiety (panic disorder, with or without agoraphobia, and generalised anxiety disorder) in adults in primary, secondary and community care. Clinical Guideline No 22

  • Sandford JJ, Forshall S, Bell C, Argyropoulos S, Rich A, D'Orlando KJ, Gammans RE, Nutt DJ (2001) Crossover trial of pagoclone and placebo in patients with DSM-IV panic disorder. J Psychopharmacol 15(3):205–208

    Article  PubMed  CAS  Google Scholar 

  • Sybirska E, Seibyl JP, Bremner JD, Baldwin RM, al-Tikriti MS, Bradberry C, Malison RT, Zea-Ponce Y, Zoghbi S, During M et al (1993) [123I]iomazenil SPECT imaging demonstrates significant benzodiazepine receptor reserve in human and nonhuman primate brain. Neuropharmacology 32(7):671–680

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors acknowledge the technical assistance of Mr. N. Uhl and the support of Dr. K D'Orlando, previously of Interneuron. The study was funded by Interneuron.

Author information

Authors and Affiliations

  1. Psychopharmacology Unit, University of Bristol, Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY, UK

    A. Lingford-Hughes, S. J. Wilson, A. Feeney & D. J. Nutt

  2. Cyclotron Unit, MRC Clinical Sciences Centre, Hammersmith Hospital, Du Cane Rd., London, UK

    A. Lingford-Hughes, A. Feeney & P. G. Grasby

Authors
  1. A. Lingford-Hughes
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. J. Wilson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Feeney
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. G. Grasby
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. J. Nutt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Lingford-Hughes.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lingford-Hughes, A., Wilson, S.J., Feeney, A. et al. A proof-of-concept study using [11C]flumazenil PET to demonstrate that pagoclone is a partial agonist. Psychopharmacology 180, 1–3 (2005). https://doi.org/10.1007/s00213-005-0060-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-005-0060-1

Keywords

Search

Navigation